Down-regulation of NF-κB protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3

Xiao Peng Yu, Teresita Bellido, Stavros C. Manolagas

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

The effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], asteroid hormone with immunomodulating properties, on nuclear factor κB (NF-κB) proteins was examined in in vitro activated normal human lymphocytes by Western blot analysis. Over a 72-hr period of activation, the expression of the 50-kDa NF- κB, p50, and its precursor, p105, was increased progressively. When cells were activated in the presence of 1,25(OH)2D3, the levels of the mature protein as well as its precursor were decreased. The effect of the hormone on the levels of p50 was demonstrable in the cytosolic and nuclear compartments; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were ineffective. Besides p50, 1,25(OH)2D3 decreased the levels of another NF-κB protein, namely c-rel. In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex formed upon incubation of nuclear extracts from activated lymphocytes with a labeled NF-κB DNA binding motif. Further, 1,25(OH)2D3 inhibited the transcriptional activity of NF-κB in Jurkat cells transiently transfected with a construct containing four tandem repeats of the NF-κB binding sequence of the immunoglobulin κ light chain gene linked to the chloramphenicol acetyltransferase reporter gene. These observations demonstrate directly that there is de novo synthesis of NF-κB during human lymphocyte activation and suggest that this process is hormonally regulated.

Original languageEnglish (US)
Pages (from-to)10990-10994
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume92
Issue number24
DOIs
StatePublished - Nov 21 1995
Externally publishedYes

Fingerprint

Calcitriol
Down-Regulation
Lymphocytes
Proto-Oncogene Proteins c-rel
Immunoglobulin Light Chain Genes
24,25-Dihydroxyvitamin D 3
Minor Planets
Hormones
Calcifediol
Nucleotide Motifs
Proteins
Chloramphenicol O-Acetyltransferase
Tandem Repeat Sequences
Jurkat Cells
Lymphocyte Activation
Reporter Genes
Western Blotting
DNA

Keywords

  • rel proteins
  • transcription factors
  • vitamin D

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Down-regulation of NF-κB protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3 . / Yu, Xiao Peng; Bellido, Teresita; Manolagas, Stavros C.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, No. 24, 21.11.1995, p. 10990-10994.

Research output: Contribution to journalArticle

@article{c5148f1f4bb542978ee7cb4d92f12daf,
title = "Down-regulation of NF-κB protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3",
abstract = "The effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], asteroid hormone with immunomodulating properties, on nuclear factor κB (NF-κB) proteins was examined in in vitro activated normal human lymphocytes by Western blot analysis. Over a 72-hr period of activation, the expression of the 50-kDa NF- κB, p50, and its precursor, p105, was increased progressively. When cells were activated in the presence of 1,25(OH)2D3, the levels of the mature protein as well as its precursor were decreased. The effect of the hormone on the levels of p50 was demonstrable in the cytosolic and nuclear compartments; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were ineffective. Besides p50, 1,25(OH)2D3 decreased the levels of another NF-κB protein, namely c-rel. In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex formed upon incubation of nuclear extracts from activated lymphocytes with a labeled NF-κB DNA binding motif. Further, 1,25(OH)2D3 inhibited the transcriptional activity of NF-κB in Jurkat cells transiently transfected with a construct containing four tandem repeats of the NF-κB binding sequence of the immunoglobulin κ light chain gene linked to the chloramphenicol acetyltransferase reporter gene. These observations demonstrate directly that there is de novo synthesis of NF-κB during human lymphocyte activation and suggest that this process is hormonally regulated.",
keywords = "rel proteins, transcription factors, vitamin D",
author = "Yu, {Xiao Peng} and Teresita Bellido and Manolagas, {Stavros C.}",
year = "1995",
month = "11",
day = "21",
doi = "10.1073/pnas.92.24.10990",
language = "English (US)",
volume = "92",
pages = "10990--10994",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "24",

}

TY - JOUR

T1 - Down-regulation of NF-κB protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3

AU - Yu, Xiao Peng

AU - Bellido, Teresita

AU - Manolagas, Stavros C.

PY - 1995/11/21

Y1 - 1995/11/21

N2 - The effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], asteroid hormone with immunomodulating properties, on nuclear factor κB (NF-κB) proteins was examined in in vitro activated normal human lymphocytes by Western blot analysis. Over a 72-hr period of activation, the expression of the 50-kDa NF- κB, p50, and its precursor, p105, was increased progressively. When cells were activated in the presence of 1,25(OH)2D3, the levels of the mature protein as well as its precursor were decreased. The effect of the hormone on the levels of p50 was demonstrable in the cytosolic and nuclear compartments; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were ineffective. Besides p50, 1,25(OH)2D3 decreased the levels of another NF-κB protein, namely c-rel. In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex formed upon incubation of nuclear extracts from activated lymphocytes with a labeled NF-κB DNA binding motif. Further, 1,25(OH)2D3 inhibited the transcriptional activity of NF-κB in Jurkat cells transiently transfected with a construct containing four tandem repeats of the NF-κB binding sequence of the immunoglobulin κ light chain gene linked to the chloramphenicol acetyltransferase reporter gene. These observations demonstrate directly that there is de novo synthesis of NF-κB during human lymphocyte activation and suggest that this process is hormonally regulated.

AB - The effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], asteroid hormone with immunomodulating properties, on nuclear factor κB (NF-κB) proteins was examined in in vitro activated normal human lymphocytes by Western blot analysis. Over a 72-hr period of activation, the expression of the 50-kDa NF- κB, p50, and its precursor, p105, was increased progressively. When cells were activated in the presence of 1,25(OH)2D3, the levels of the mature protein as well as its precursor were decreased. The effect of the hormone on the levels of p50 was demonstrable in the cytosolic and nuclear compartments; it required between 4 and 8 hr and was specific, as 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 were ineffective. Besides p50, 1,25(OH)2D3 decreased the levels of another NF-κB protein, namely c-rel. In addition, 1,25(OH)2D3 decreased the abundance of a specific DNA-protein complex formed upon incubation of nuclear extracts from activated lymphocytes with a labeled NF-κB DNA binding motif. Further, 1,25(OH)2D3 inhibited the transcriptional activity of NF-κB in Jurkat cells transiently transfected with a construct containing four tandem repeats of the NF-κB binding sequence of the immunoglobulin κ light chain gene linked to the chloramphenicol acetyltransferase reporter gene. These observations demonstrate directly that there is de novo synthesis of NF-κB during human lymphocyte activation and suggest that this process is hormonally regulated.

KW - rel proteins

KW - transcription factors

KW - vitamin D

UR - http://www.scopus.com/inward/record.url?scp=0028972468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028972468&partnerID=8YFLogxK

U2 - 10.1073/pnas.92.24.10990

DO - 10.1073/pnas.92.24.10990

M3 - Article

C2 - 7479923

AN - SCOPUS:0028972468

VL - 92

SP - 10990

EP - 10994

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 24

ER -